Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Protein Studies

Principle and Setup: Harnessing the Power of the HA Tag Peptide

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic nine-amino acid sequence (YPYDVPDYA) derived from the influenza hemagglutinin epitope. As a gold-standard epitope tag for protein detection and purification, the HA tag peptide enables researchers to precisely track, purify, and manipulate HA-tagged fusion proteins across complex biochemical workflows. Its small size minimizes steric hindrance, while high affinity for anti-HA antibodies underpins robust, specific detection and competitive elution, crucial for immunoprecipitation with Anti-HA antibody and related applications.

With a purity exceeding 98% (verified by both HPLC and mass spectrometry), and exceptional solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water), this peptide is ideally suited for high-sensitivity applications such as protein-protein interaction studies, exosome research, and ubiquitin pathway mapping. The product’s stability—best preserved desiccated at -20°C—ensures reproducible performance in demanding molecular workflows.

Step-by-Step Workflow: Enhancing Immunoprecipitation and Protein Purification

1. Construct Design and Fusion Expression

Incorporate the HA tag sequence (YPYDVPDYA) at the N- or C-terminus of the protein of interest using the appropriate ha tag dna sequence or ha tag nucleotide sequence. Verify in-frame fusion and expression using standard molecular cloning and expression protocols. For mammalian or bacterial systems, ensure that the HA tag does not disrupt native folding or function.

2. Immunoprecipitation with Anti-HA Antibody

Lyse cells expressing the HA-tagged protein under non-denaturing conditions to preserve native complexes. Employ Anti-HA magnetic beads or conventional Anti-HA antibodies for selective capture. Incubation times of 1–2 hours at 4°C are typically sufficient for robust binding, leveraging the high-affinity interaction with the HA epitope tag. Wash beads thoroughly to remove non-specific proteins, using buffers compatible with the HA peptide’s solubility profile.

3. Competitive Elution with HA Peptide

Add the HA fusion protein elution peptide at optimized concentrations (commonly 0.5–2 mg/mL) to competitively displace bound HA-tagged proteins from the antibody. This approach preserves native protein conformations and protein-protein interactions, a key advantage for downstream analyses such as mass spectrometry or enzymatic assays. Elution is typically complete within 30–60 minutes at 4°C.

4. Downstream Analysis

Analyze eluted proteins by SDS-PAGE, western blot, or functional assays. The use of a high-quality molecular biology peptide tag, such as the Influenza Hemagglutinin (HA) Peptide, ensures minimal background and high yield, accelerating protein characterization and discovery workflows.

Advanced Applications and Comparative Advantages

1. Exosome Research and ESCRT-Independent Pathways

The emergence of exosome research has placed new demands on epitope tagging strategies. In the landmark study RAB31 marks and controls an ESCRT-independent exosome pathway (Cell Research, 2021), researchers leveraged molecular tags akin to the HA peptide to dissect the biogenesis of intraluminal vesicles and exosome trafficking. The study highlights the importance of precise, non-disruptive tags for tracking protein localization and dynamics in complex vesicular pathways—roles the HA tag fulfills exceptionally well due to its compact size, solubility, and competitive elution properties.

Advanced workflows using the HA peptide facilitate the study of exosome cargo sorting, enabling the dissection of protein-protein and protein-lipid interactions within multivesicular endosomes. The ability to recover functional complexes via gentle competitive binding to Anti-HA antibody maximizes the integrity of exosome proteomics experiments.

2. Ubiquitin Signaling and Protein-Protein Interaction Studies

Recent analyses, such as those discussed in "Influenza Hemagglutinin (HA) Peptide: Advanced Tag for Ub...", have demonstrated how the HA tag peptide enables dissection of ubiquitin signaling events, particularly in cancer research. By providing a reliable handle for immunoprecipitation and competitive elution, the HA peptide supports the identification of transient and low-abundance interactors, facilitating new insights into post-translational modification networks.

Moreover, the article "Influenza Hemagglutinin (HA) Peptide: Precision Tagging f..." highlights how the HA peptide’s high purity and solubility outperform traditional tags in sensitive interactome mapping and ubiquitin pathway analysis, offering enhanced signal-to-noise ratios and reproducibility.

3. Complementing and Extending Existing Tag Strategies

Compared to alternative tags (e.g., FLAG, Myc, or V5), the HA tag peptide exhibits lower background in mammalian cell lysates and supports more stringent competitive elution. As discussed in "Influenza Hemagglutinin (HA) Peptide: Advancing Precision...", the unique sequence specificity and well-characterized antibody repertoire further distinguish the HA tag as a first-choice for challenging protein purification and detection scenarios.

Troubleshooting and Optimization Tips

• Solubility Optimization: Prepare fresh working solutions of the HA peptide in water, ethanol, or DMSO at concentrations tailored to your application. For immunoprecipitation, use ≥1 mg/mL in a buffer compatible with the antibody and target protein.
• Minimizing Non-Specific Binding: Incorporate stringent wash steps with high-salt buffer or mild detergents to reduce background. Pre-clearing lysates with control beads can further improve specificity.
• Elution Efficiency: If elution is suboptimal, increase peptide concentration incrementally or extend incubation time. Confirm the presence of the HA tag on your fusion protein by western blot prior to immunoprecipitation.
• Storage and Stability: Always store lyophilized HA peptide desiccated at -20°C. Avoid repeated freeze-thaw cycles and prepare fresh peptide solutions immediately before use, as long-term storage of solutions can reduce activity.
• Antibody Selection: Use high-affinity monoclonal anti-HA antibodies for best results; titrate antibody and peptide concentrations during initial optimization.

For more advanced troubleshooting and optimization strategies, the article "Translational Protein Science Transformed: Mechanistic Ma..." offers a comprehensive roadmap for designing high-fidelity protein workflows leveraging the HA tag.

Future Outlook: Next-Generation Applications and Translational Impact

The versatility of the Influenza Hemagglutinin (HA) Peptide ensures its continued relevance as a protein purification tag in emerging applications, from single-cell proteomics to live-cell imaging and exosome engineering. As mechanistic insight into exosome biogenesis and ESCRT-independent pathways expands—exemplified by the RAB31 exosome pathway study—the demand for robust, high-purity tags will only increase.

Looking forward, the integration of the HA tag peptide into multi-epitope tagging strategies, proximity labeling, and high-throughput screening promises to accelerate discovery in cellular signaling, cancer biology, and regenerative medicine. The high solubility and specificity of the HA peptide, as supplied by APExBIO, will continue to underpin reproducible, high-impact research across the molecular biosciences.

Conclusion

The Influenza Hemagglutinin (HA) Peptide represents a meticulously validated solution for next-generation protein detection, purification, and interaction studies. Its unique properties—compact sequence, high purity, and flexible solubility—empower researchers to push the boundaries of molecular biology and translational research. By leveraging the trusted quality of APExBIO, scientists can confidently integrate the HA tag into advanced experimental designs, ensuring reproducibility and precision at every step.